Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Current Assets: 2018-2024

Historic Current Assets for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2024 value amounting to $928.6 million.

  • Bicycle Therapeutics' Current Assets fell 23.53% to $738.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $738.8 million, marking a year-over-year decrease of 23.53%. This contributed to the annual value of $928.6 million for FY2024, which is 65.27% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Current Assets of $928.6 million as of FY2024, which was up 65.27% from $561.9 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Current Assets registered a high of $928.6 million during FY2024, and its lowest value of $155.7 million during FY2020.
  • Over the past 3 years, Bicycle Therapeutics' median Current Assets value was $561.9 million (recorded in 2023), while the average stood at $620.0 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 194.47% in 2021, then fell by 19.45% in 2022.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Current Assets stood at $155.7 million in 2020, then surged by 194.47% to $458.6 million in 2021, then declined by 19.45% to $369.4 million in 2022, then soared by 52.11% to $561.9 million in 2023, then skyrocketed by 65.27% to $928.6 million in 2024.